471 related articles for article (PubMed ID: 27927678)
41. Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.
Akyüz C; Kıratlı H; Şen H; Aydın B; Tarlan B; Varan A
Ophthalmologica; 2015; 234(4):227-32. PubMed ID: 26368674
[TBL] [Abstract][Full Text] [Related]
42. Intra-arterial chemotherapy for retinoblastoma in 341 consecutive eyes (1,292 infusions): comparative analysis of outcomes based on patient age, race, and sex.
Shields CL; Dockery PW; Yaghy A; Duffner ER; Levin HJ; Taylor OS; Sajjadi Z; Lally SE; Shields JA; Rosenwasser R; Tjoumakaris S; Jabbour P
J AAPOS; 2021 Jun; 25(3):150.e1-150.e9. PubMed ID: 34044113
[TBL] [Abstract][Full Text] [Related]
43. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.
Abramson DH; Fabius AW; Francis JH; Marr BP; Dunkel IJ; Brodie SE; Escuder A; Gobin YP
Ophthalmic Genet; 2017; 38(1):16-21. PubMed ID: 28095092
[TBL] [Abstract][Full Text] [Related]
44. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
Shields CL; Bianciotto CG; Jabbour P; Ramasubramanian A; Lally SE; Griffin GC; Rosenwasser R; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
[TBL] [Abstract][Full Text] [Related]
45. Globe Salvage With Intra-Arterial Topotecan-Melphalan Chemotherapy in Children With a Single Eye.
Leal-Leal CA; Asencio-López L; Higuera-Calleja J; Bernal-Moreno M; Bosch-Canto V; Chávez-Pacheco J; Isaac-Otero G; Beck-Popovic M
Rev Invest Clin; 2016; 68(3):137-42. PubMed ID: 27409000
[TBL] [Abstract][Full Text] [Related]
46. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THE MANAGEMENT OF NEOVASCULARIZATION IN RETINOBLASTOMA AFTER INTRAVENOUS AND/OR INTRAARTERIAL CHEMOTHERAPY: Long-Term Outcomes in a Series of 35 Eyes.
Stathopoulos C; Gaillard MC; Moulin A; Puccinelli F; Beck-Popovic M; Munier FL
Retina; 2019 Dec; 39(12):2273-2282. PubMed ID: 30312257
[TBL] [Abstract][Full Text] [Related]
47. Risk Factors for Acute Choroidal Ischemia after Intra-arterial Melphalan for Retinoblastoma: The Role of the Catheterization Approach.
Stathopoulos C; Bartolini B; Marie G; Beck-Popovic M; Saliou G; Munier FL
Ophthalmology; 2021 May; 128(5):754-764. PubMed ID: 32956742
[TBL] [Abstract][Full Text] [Related]
48. RHEGMATOGENOUS RETINAL DETACHMENT AFTER INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: The 2016 Founders Award Lecture.
Shields CL; Say EAT; Pefkianaki M; Regillo CD; Caywood EH; Jabbour PM; Shields JA
Retina; 2017 Aug; 37(8):1441-1450. PubMed ID: 27787452
[TBL] [Abstract][Full Text] [Related]
49. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.
Berry JL; Jubran R; Kim JW; Wong K; Bababeygy SR; Almarzouki H; Lee TC; Murphree AL
Pediatr Blood Cancer; 2013 Apr; 60(4):688-93. PubMed ID: 22997170
[TBL] [Abstract][Full Text] [Related]
50. Chemoreduction for unilateral retinoblastoma.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
[TBL] [Abstract][Full Text] [Related]
51. Intra-Arterial Chemotherapy for Retinoblastoma in Infants ≤10 kg: 74 Treated Eyes with 222 IAC Sessions.
Sweid A; Hammoud B; Weinberg JH; Texakalidis P; Xu V; Shivashankar K; Baldassari MP; Das S; Ramesh S; Tjoumakaris S; Shields CL; Ancona-Lezama D; Lim LS; Dalvin LA; Jabbour P
AJNR Am J Neuroradiol; 2020 Jul; 41(7):1286-1292. PubMed ID: 32586963
[TBL] [Abstract][Full Text] [Related]
52. Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.
Say EA; Iyer PG; Hasanreisoglu M; Lally SE; Jabbour P; Shields JA; Shields CL
J AAPOS; 2016 Aug; 20(4):337-42. PubMed ID: 27328850
[TBL] [Abstract][Full Text] [Related]
53. Preservation of retinoblastoma group E eyes with neovascular glaucoma using intravenous chemotherapy: risk factors and outcomes.
Rao R; Honavar SG; Reddy VP
Br J Ophthalmol; 2019 Dec; 103(12):1856-1861. PubMed ID: 30796055
[TBL] [Abstract][Full Text] [Related]
54. Successful conservative treatment of massive choroidal relapse in 2 retinoblastoma patients monitored by ultrasound biomicroscopy and/or spectral domain optic coherence tomography.
Stathopoulos C; Gaillard MC; Puccinelli F; Maeder P; Hadjistilianou D; Beck-Popovic M; Munier FL
Ophthalmic Genet; 2018 Apr; 39(2):242-246. PubMed ID: 29099668
[TBL] [Abstract][Full Text] [Related]
55. Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results.
Marr BP; Brodie SE; Dunkel IJ; Gobin YP; Abramson DH
Br J Ophthalmol; 2012 Oct; 96(10):1300-3. PubMed ID: 22863945
[TBL] [Abstract][Full Text] [Related]
56. Update on intra-arterial chemotherapy for retinoblastoma.
Zanaty M; Barros G; Chalouhi N; Starke RM; Manasseh P; Tjoumakaris SI; Shields CL; Hasan D; Bulsara K; Rosenwasser RH; Jabbour P
ScientificWorldJournal; 2014; 2014():869604. PubMed ID: 25405236
[TBL] [Abstract][Full Text] [Related]
57. Intra-arterial chemotherapy for retinoblastoma: Two-year results from tertiary eye-care center in India.
Rishi P; Sharma T; Sharma M; Maitray A; Dhami A; Aggarwal V; Munusamy S; Ravikumar R; Ramamurthy S
Indian J Ophthalmol; 2017 Apr; 65(4):311-315. PubMed ID: 28513496
[TBL] [Abstract][Full Text] [Related]
58. The success of primary chemotherapy for group D heritable retinoblastoma.
Cohen VM; Kingston J; Hungerford JL
Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
[TBL] [Abstract][Full Text] [Related]
59. Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy.
Biewald EM; Bornfeld N; Metz KA; Schlüter S; Kiefer T; Radbruch A; Göricke S; Sirin S; Ketteler P; Bechrakis NE
Br J Ophthalmol; 2020 Aug; 104(8):1171-1175. PubMed ID: 31676593
[TBL] [Abstract][Full Text] [Related]
60. Intravenous chemoreduction or intra-arterial chemotherapy for cavitary retinoblastoma: long-term results.
Rojanaporn D; Kaliki S; Bianciotto CG; Iturralde JC; Say EA; Shields CL
Arch Ophthalmol; 2012 May; 130(5):585-90. PubMed ID: 22652844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]